Sort
17,054 grants matching “genome editing”
Preventing and reversing mitochondrial Leigh syndrome with hypoxia
$537,347Vamsi Krishna Mootha · Massachusetts General Hospital · R01 · FY2023 · NS
Viscoelastic Properties of Normal and OA Chondrons
$537,335Farshid Guilak · Washington University · R01 · FY2020 · AG
Enhancing Editing Efficiency, Versatility and Guide Design of CHyMErA Screening Platform
$537,325Michael Aregger · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Evaluation of genetic variants affecting platelet function with CRISPR HDR in human megakaryocytes
$536,992Jesse Rowley · Utah State Higher Education System--University Of Utah · R01 · FY2025 · HL
Evaluation of genetic variants affecting platelet function with CRISPR HDR in human megakaryocytes
$536,992Jesse Rowley · University Of Utah · R01 · FY2023 · HL
Disabling the replication-competent HIV provirus in the reservoir by combined CRISPR-Cas action
$536,971Benjamin Berkhout · Academical Medical Center · R01 · FY2022 · AI
Genetic Analysis of Genes Controlling a Position Effect
$536,915Jasper D Rine · University Of California Berkeley · R01 · FY2017 · GM
Engineering Human Heart Tissues with Polyploid Cardiomyocytes
$536,797Nenad Bursac · Duke University · R01 · FY2024 · HL
Retinal Pigmented Epithelium Epigenome Dysregulation With Aging and Modulation by Diet
$536,749Willard M Freeman · Oklahoma Medical Research Foundation · R01 · FY2025 · EY
Lysosomal Diseases
$536,727Rosa Puertollano-Moro · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Genetic Determinants of Tumor Growth and Drug Sensitivity in EGFR Mutant Lung Cancer
$536,716Katerina Abigail Politi · Yale University · R01 · FY2024 · CA
Molecular Mechanisms of Insulin Resistance Associated Loci
$536,612Thomas None Quertermous · Stanford University · R01 · FY2018 · DK
Editing of the AAT locus using novel base editing and prime editing technologies
$536,581Wen Xue · Univ Of Massachusetts Med Sch Worcester · P01 · FY2024 · HL
Modulation of Immune responses to gene therapy by Creation of AAV-specific Chimeric antigen receptor regulatory T cells (CAR-Tregs)
$536,581Allison May Keeler-Klunk · Univ Of Massachusetts Med Sch Worcester · P01 · FY2024 · HL
Impact of Loss-of-function NADPH Oxidase Variants on B cell Activation in SLE
$536,554Shaun William Jackson · Seattle Children'S Hospital · R01 · FY2021 · AR
Impact of Loss-of-function NADPH Oxidase Variants on B cell Activation in SLE
$536,554Shaun William Jackson · Seattle Children'S Hospital · R01 · FY2023 · AR
Viscoelastic Properties of Normal and OA Chondrons
$536,421Farshid Guilak · Washington University · R01 · FY2019 · AG
DEVELOPMENT OF AAV-CRISPR/CAS9-BASED THERAPIES FOR CONE ROD DYSTROPHY
$536,347Shannon Elizabeth Boye · University Of Florida · R01 · FY2021 · EY
Development of Technologies for Efficient In Vivo Prime Editing
$536,345Pablo Perez-Pinera · University Of Illinois At Urbana-Champaign · R01 · FY2023 · GM
Development of Technologies for Efficient In Vivo Prime Editing
$536,345Pablo Perez-Pinera · University Of Illinois At Urbana-Champaign · R01 · FY2022 · GM
Development of Technologies for Efficient In Vivo Prime Editing
$536,345Pablo Perez-Pinera · University Of Illinois At Urbana-Champaign · R01 · FY2024 · GM
Development and characterization of mouse models of RP59 DHDDS deficiency
$536,290Steven J Pittler · University Of Alabama At Birmingham · R01 · FY2021 · EY
Behavioral Science Core
$536,191Alan S Wayne · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Development of Technologies for Efficient In Vivo Prime Editing
$535,871Pablo Perez-Pinera · University Of Illinois At Urbana-Champaign · R01 · FY2021 · GM
Elucidating the molecular basis of piperaquine resistance and the role of altered hemoglobin metabolism in Plasmodium falciparum
$535,760David Armand Fidock · Columbia University Health Sciences · R01 · FY2017 · AI